Novozymes 2008: outlook 2009
- Publisher
- Elsevier Science
- Year
- 2009
- Weight
- 59 KB
- Volume
- 2009
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
โฆ Synopsis
In view of the economic environment, Novozymes considers its current 2009 growth outlook satisfactory. The slowdown in 4Q 2008 is not considered a reliable indicator of 2009 full-year performance. Sales growth is forecast at 8-13% (in terms of DKR), and operating profit is expected to grow by 10-15% (DKR terms). Growth in sales of enzymes for US bioethanol production is expected to follow the Renewable Fuel Standard. Total expected investments in 2009 are DKR 1.3-1.5 bn. This includes the building of a new enzyme plant in Nebraska, USA, at a cost of $160-200 M in 2009/2010. During 2009, DKR 200-300 M will be invested in the expansion of enzyme capacity at existing facilities, to optimize flexibility for the detergent industry. Also, in 2009/2010 BioBusiness will build a plant for production of high-grade hyaluronic acid (bHA) in Tianjin, China, at Novozymes' existing site. Total investment is expected to be DKR 200-300 M, evenly distributed over the period. For 2009 free cash flow before acquisitions is expected to be DKK 100-300 M. A table contains key financial data that has been forecast for 2009, and sales outlook by product area. Sales of detergent enzymes are expected to rise by 4-8%, technical enzyme sales by 15-20%, food enzyme sales by 5-9%, and feed enzyme sales by 15-20%. Sales of microorganisms are expected to be the same as for 2008, and biopharmaceutical ingredient sales are expected to fall by 10%.
๐ SIMILAR VOLUMES
Novecare provides high-performance products and solutions to a wide range of industries including cosmetics, detergents, agrochemicals and oil, as well as industrial applications. Novecare's Home & Personal Care and Agro segments demonstrated resilience while Oilfield and Industrial applications exp
applications for automobiles, ITrelated products, civil engineering and construction works falling due to the global economic downturn triggered by the US financial crisis. The surfactant market, however, is forecast to remain stable as applications for daily commodities such as soap, shampoos, and